Matrix Private Equity Partners has realised over 3.3x its original investment of £2.3m through the sale of its shareholding in AIM-listed BBI Holdings Plc. Matrix originally invested in BBI, a healthcare business that focuses on diagnostics and diabetes, in 2000, before listing it on AIM in 2004. The final realisation opportunity arose through BBI’s recommended all cash or shares offer by Inverness Medical Innovations. Matrix funds have received £7.8 million proceeds over the seven year life of the investment, achieving an IRR of 31%.
Michael Holgate has been promoted to partner, while Andy Dyer is now a director
Axis Participaciones and Sofimac Innovation, through Pertinence Invest 2, also take part in the round
Acquisition of processing company, rebranded as Millhouse Berlin, is the GP's fourth deal of 2020
Sale ends a five-year holding period, during which Aurelius sold Mez's Italy-based subsidiary